A detailed history of Bank Of America Corp transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 36,056 shares of NAUT stock, worth $64,179. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,056
Previous 26,708 35.0%
Holding current value
$64,179
Previous $62,000 64.52%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.24 - $3.08 $20,939 - $28,791
9,348 Added 35.0%
36,056 $102,000
Q2 2024

Aug 14, 2024

BUY
$2.22 - $3.0 $37,724 - $50,979
16,993 Added 174.92%
26,708 $62,000
Q1 2024

May 15, 2024

SELL
$2.41 - $3.18 $78,332 - $103,359
-32,503 Reduced 76.99%
9,715 $28,000
Q4 2023

Feb 14, 2024

BUY
$2.34 - $3.39 $16,595 - $24,041
7,092 Added 20.19%
42,218 $126,000
Q2 2023

Aug 14, 2023

SELL
$2.21 - $4.52 $1,949 - $3,986
-882 Reduced 2.45%
35,126 $135,000
Q1 2023

May 12, 2023

SELL
$1.67 - $2.77 $6,967 - $11,556
-4,172 Reduced 10.38%
36,008 $99,000
Q4 2022

Feb 10, 2023

BUY
$1.55 - $2.47 $9,870 - $15,728
6,368 Added 18.83%
40,180 $72,000
Q3 2022

Nov 14, 2022

SELL
$1.96 - $3.13 $6,860 - $10,955
-3,500 Reduced 9.38%
33,812 $72,000
Q2 2022

Aug 12, 2022

SELL
$2.64 - $4.84 $104,066 - $190,787
-39,419 Reduced 51.37%
37,312 $100,000
Q1 2022

May 16, 2022

BUY
$3.5 - $5.3 $254,023 - $384,663
72,578 Added 1747.6%
76,731 $333,000
Q4 2021

Feb 08, 2022

SELL
$4.45 - $6.21 $77,643 - $108,352
-17,448 Reduced 80.77%
4,153 $22,000
Q3 2021

Nov 15, 2021

BUY
$6.14 - $10.1 $123,420 - $203,020
20,101 Added 1340.07%
21,601 $133,000
Q2 2021

Sep 13, 2021

BUY
$9.04 - $14.19 $13,559 - $21,285
1,500 New
1,500 $15,000

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $222M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.